Praxis Precision Medicines to Present at Upcoming Investor Conferences

Rhea-AI Summary

Praxis Precision Medicines (NASDAQ: PRAX), a clinical-stage biopharmaceutical company, has announced its participation in two upcoming virtual investor conferences. The first event is the Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit on July 13, 2021, featuring a fireside chat at 3:00 p.m. ET. The second is the William Blair Biotech Focus Conference on July 15, 2021, with an 'Updates in Neuropsych' panel at 12:00 p.m. ET. Both events will be webcasted and available for replay for 90 days post-event. For more details, visit www.praxismedicines.com.

CAMBRIDGE, Mass., July 06, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal imbalance, today announced that management will participate in the following upcoming virtual investor conferences:

• Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit
  Fireside chat on Tuesday, July 13, 2021 at 3:00 p.m. ET

• William Blair Biotech Focus Conference 2021
  ‘Updates in Neuropsych’ panel on Thursday, July 15, 2021 at 12:00 p.m. ET
  

The events will be available via webcast through the Events & Presentations page of the Investors + Media section of the company’s website at www.praxismedicines.com. Replays of the webcasts will be available for 90 days following the events.

About Praxis
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders (CNS) characterized by neuronal imbalance. Praxis is applying insights from genetic epilepsies to broader neurological and psychiatric disorders, using our understanding of shared biological targets and circuits in the brain. Praxis has established a broad portfolio, including multiple disclosed programs across CNS disorders including depression, epilepsy, movement disorders and pain syndromes, with three clinical-stage product candidates. For more information, please visit www.praxismedicines.com and follow us on LinkedIn and Twitter.

FAQ

What investor conferences is Praxis Precision Medicines participating in July 2021?

Praxis Precision Medicines is participating in the Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit on July 13, 2021, and the William Blair Biotech Focus Conference on July 15, 2021.

What is the schedule for the Cowen Psychedelics Summit?

The Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit will feature a fireside chat on July 13, 2021, at 3:00 p.m. ET.

When will the William Blair Biotech Focus Conference take place?

The William Blair Biotech Focus Conference will take place on July 15, 2021, with an 'Updates in Neuropsych' panel scheduled for 12:00 p.m. ET.

Where can I watch the Praxis Precision Medicines conference presentations?

The conference presentations will be available via webcast on the Events & Presentations page of the Investors + Media section on the Praxis website.

How long will the webcasts of the conferences be available for replay?

The webcasts will be available for replay for 90 days following the events.